vimarsana.com
Home
Live Updates
Domvanalimab Zimberelimab Milestones - Breaking News
Pages:
Latest Breaking News On - Domvanalimab zimberelimab milestones - Page 1 : vimarsana.com
Arcus Biosciences Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides a Pipeline Update
Arcus and Gilead announced an additional equity investment of $320 million into Arcus and modifications to their domvanalimab + zimberelimab clinical program to focus on the highest unmet medical.
Terry rosen
Johanna mercier
Development rd expenses
Exchange commission on
Exchange commission
Company annual report on form
Arcus biosciences inc
Arcus biosciences
Chief commercial officer
Domvanalimab zimberelimab milestones
Safety data
Overall survival
Synthetic control arm
Fourth quarter
Full year
Cash equivalents
Arcus Biosciences Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides a Pipeline Update
HAYWARD, Calif. (BUSINESS WIRE) Feb 21, 2024
United states
Johanna mercier
Terry rosen
Holli kolkey
Development rd expenses
Corporate communications
Arcus biosciences inc
Exchange commission on
Company annual report on form
Exchange commission
Chief commercial officer
Domvanalimab zimberelimab milestones
Safety data
Overall survival
Synthetic control arm
Fourth quarter
vimarsana © 2020. All Rights Reserved.